We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Groupon
GRPN
$774M
| $1.78M | ﹤0.01% |
98,447
+50,884
| +107% | +$1.13M |
|
1027
Carlisle Companies
CSL
$12.8B
| $1.78M | ﹤0.01% |
14,901
-3,152
| -17% | -$379K |
|
1028
TriCo Bancshares
TCBK
$1.73B
| $1.77M | ﹤0.01% |
58,120
-13,381
| -19% | -$382K |
|
|
LMNX
1029
DELISTED
Luminex Corp
LMNX
| $1.76M | ﹤0.01% |
54,272
+53,591
| +7,869% | +$1.7M |
|
1030
Evergy
EVRG
$18.7B
| $1.76M | ﹤0.01% |
29,716
+1,183
| +4% | +$70.1K |
|
1031
Aflac
AFL
$58.6B
| $1.76M | ﹤0.01% |
48,808
+26,725
| +121% | +$965K |
|
|
ITCI
1032
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $1.75M | ﹤0.01% |
68,359
+24,906
| +57% | +$504K |
|
1033
Madison Square Garden
MSGS
$9.53B
| $1.75M | ﹤0.01% |
11,929
+4,231
| +55% | +$699K |
|
1034
Oportun Financial
OPRT
$361M
| $1.75M | ﹤0.01% |
130,000
+29,592
| +29% | +$275K |
|
1035
Allegion
ALLE
$13.1B
| $1.75M | ﹤0.01% |
17,072
-45,528
| -73% | -$4.49M |
|
1036
Wendy's
WEN
$1.36B
| $1.74M | ﹤0.01% |
80,091
+34,737
| +77% | +$690K |
|
1037
Calix
CALX
$2.24B
| $1.74M | ﹤0.01% |
+116,763
| New | +$1.34M |
|
1038
Costamare
CMRE
$1.88B
| $1.74M | ﹤0.01% |
312,394
+7,949
| +3% | +$38.7K |
|
|
CXO
1039
DELISTED
CONCHO RESOURCES INC.
CXO
| $1.74M | ﹤0.01% |
33,713
+31,370
| +1,339% | +$1.73M |
|
|
APLT
1040
DELISTED
Applied Therapeutics
APLT
| $1.73M | ﹤0.01% |
47,848
+39,478
| +472% | +$1.65M |
|
1041
Steel Dynamics
STLD
$35.1B
| $1.73M | ﹤0.01% |
66,272
-5,680
| -8% | -$142K |
|
1042
Lamb Weston
LW
$6.41B
| $1.72M | ﹤0.01% |
26,896
-146,639
| -85% | -$8.86M |
|
1043
Flowers Foods
FLO
$1.32B
| $1.72M | ﹤0.01% |
76,716
+7,426
| +11% | +$167K |
|
1044
Axsome Therapeutics
AXSM
$10.9B
| $1.71M | ﹤0.01% |
20,731
-14,307
| -41% | -$1.1M |
|
1045
Toro Company
TTC
$8.83B
| $1.7M | ﹤0.01% |
25,649
-1,374
| -5% | -$90.2K |
|
1046
Aecom
ACM
$8.18B
| $1.7M | ﹤0.01% |
45,231
-30,702
| -40% | -$1.1M |
|
|
SRCL
1047
DELISTED
Stericycle Inc
SRCL
| $1.7M | ﹤0.01% |
30,368
+7,572
| +33% | +$394K |
|
1048
Eagle Bancorp
EGBN
$869M
| $1.7M | ﹤0.01% |
51,868
+33,202
| +178% | +$1.06M |
|
|
AXON
1049
Axon Enterprise
AXON
$36.8B
| $1.7M | ﹤0.01% |
17,294
+782
| +5% | +$63.2K |
|
1050
State Street Utilities Select Sector SPDR ETF
XLU
$21.6B
| $1.69M | ﹤0.01% |
60,000
+8,000
| +15% | +$231K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.